| Literature DB >> 31316593 |
Railson de Oliveira Ferreira1, Raíra de Brito Silva1, Marcela Baraúna Magno2, Anna Paula Costa Ponte Sousa Carvalho Almeida1, Nathália Carolina Fernandes Fagundes1, Lucianne Cople Maia2, Rafael Rodrigues Lima3.
Abstract
Periodontitis is an inflammatory disease of dental supporting tissues (gingiva, periodontal ligament, and bone) and it has been suggested as a possible etiology for rheumatoid arthritis (RA). In this systematic review, we aim to verify if periodontitis represents a risk factor for RA. Electronic databases were consulted until March 2018 considering eligibility criteria focusing on: (P, participants) adults; (E, exposure) with periodontitis; (C, comparison) without periodontitis; and (O, outcome) development of RA. Quality assessment of studies and risk-of-bias evaluation were also performed. To undertake a quantitative analysis, the number of persons with RA and a total number of participants for the case group (with periodontitis) and control group (without periodontitis) were used to calculate the odds ratio (OR) with a 95% confidence interval (CI). A total of 3888 articles were identified, and nine studies were considered eligible. Seven of 9 articles suggested an association among diseases by the common pro-inflammatory profiles. The pooled analysis of 3 articles showed a higher RA prevalence for persons with periodontitis (n = 1177) than controls (n = 254) (OR 1.97; CI 1.68-2.31; p < 0.00001). However, considerable heterogeneity among studies was verified (I2 = 96%, p < 0.00001). Periodontitis may represent a risk factor for RA by heredity, bacterial infection, and the pro-inflammatory profile shared between both diseases. Although most of the elective studies report an association between periodontitis and RA, the quantitative analysis showed a high heterogeneity, leading to the need for further studies.Entities:
Keywords: periodontitis; rheumatoid arthritis; systematic review
Year: 2019 PMID: 31316593 PMCID: PMC6620730 DOI: 10.1177/1759720X19858514
Source DB: PubMed Journal: Ther Adv Musculoskelet Dis ISSN: 1759-720X Impact factor: 5.346
Quality assessment and risk of bias according to Fowkes and Fulton.[13]
| Guideline | Checklist | Description |
|---|---|---|
| Study design appropriate to objectives? | Objective common designPrevalence cross-sectionalPrognosis cohortTreatment-controlled trialCause cohort, case control, cross-sectional | The type of study was marked in the appropriate type of study; if the type of study was appropriate according to the study design was marked as ‘0’ and as ‘++’ if it was not appropriate |
| Study sample representative? | Source of sampleSampling methodSample sizeEntry criteria/exclusionNonrespondents | The domain was considered (0) in cases of detailed origin, (+) to a specified origin of only one group, and (++) in cases of absence of specification of the origin of the groupsThe item was assigned (0) for a full description of sampling method, (+) for poor or no description of sample method, with no problem in matching between groups and (++) for poor or no description of sample method, interfering in the matching of the groupsA minor problem (+) was considered when the sample was not representative or did not report a sample calculation; to a major problem, (++) was considered when no sample calculation was provided and the number of participants was less than 50 participants; (0) was considered in the absence of the above factorsA minor problem (+) was assigned when the control and case group reported current use of antibiotics or anti-inflammatories, diabetes, smoking, or pregnancy, and in the case of presence of more than two previously mentioned items, it was considered a major problem (++)(0) was assigned when there was no refusal to participate in the study, (+) was assigned when there was a refusal, but did not compromise the sample, and (++) when there were refusal and impairment of the sample size |
| Control group acceptable? | Definition of controlsSource of controlsMatching/randomizationComparable characteristics | (0) was assigned when all characteristics of a control group were described; (+) when any information was considered originating from the control group, the selection criteria, or a different origin between case and control groups; and (++) when two or more items were described in previously mentioned items(0) was assigned when the control group was referred; (+) when the origin of groups was different, but with reasons; and (++) when the groups present different origins without explanationIn this item, (0) was assigned to cases of randomized/matched groups; (+) to cases of no description of randomization, but with the matching of groups; and (++) to no description of randomization or matching(0) was assigned to matched groups or not matched by the impossibility of being subsequently adjusted and (++) the presence of unpaired variables that were not paired or adjusted |
| Quality of measurements and outcomes? | ValidityReproducibilityBlindnessQuality control | (0) was assigned when the evaluation method applied was appropriate; (+) when using a single method, but with appropriate sensitivity with good specificity; (++) when using a single method, without an adequate specificity or good sensitivity(0) was assigned to whether the evaluation methods were well described; (+) when lacking description of any step of the method, for example, the identification of patients from the groups studied in laboratory samples, evaluations at different times or application of different methods between groups of specific pathology; (++) when two or more of the previous items are presentWhen the condition of the study participants was considered ‘blind,’ (0) was assigned; in cases of ‘not blind,’ (++) was assignedIt was considered a problem when examiners were not submitted to a standard error analysis (Kappa error analysis); when unqualified students were assessed without supervision by a qualified dentist; when analysis of periodontitis was only radiographic or depth of periodontal pockets only was used; evaluation of less than three dental sites or no mention how many faces were evaluated; two of these problems were identified, it was considered a minor problem (+), and major problem (++) if more than two of these characteristics were described |
| Completeness | ComplianceDropoutsDeathsMissing data | (0) was assigned for a sample size that remains the same from beginning to end or decreases without compromising the power of the test; (+) for differences in sample size at the end of the study, compromising the power of the test, but with reasons and adjusts; (++) for difference in sample size at the end of the study, compromising the power of the test, without explanationThe (0) was scored when there is no loss during the study, (+) when there was a withdrawal involving the inclusion criteria, such as age, sex, and (++) when there was withdrawal and it compromised more than one criterionThis item was scored as not applicable (NA), using the PECO strategyIn this item, (0) was assigned to cases of randomized/matched groups; (+) to cases of no description of randomization, but with the matching of groups; and (++) to no description of randomization or matching |
| Distorting influences? | Extraneous treatmentsContaminationChanges over timeConfounding factorsDistortion reduced by analysis | In this item, (0) was considered when there were no external influences; (+) when there were external influences, but did not interfere with the results; (++) when there were external influences and they did interfere with the resultsThis item was scored as NA, using the PECO strategyIn this item, (0) was assigned to data collected in the same period; (+) to data collected from the control and study groups at different times that might cause distortions; (++) when the previous item was associated with data from studies already publishedA problem was considered in the case of men and women under the age of 45, being menopausal, being a smoker, being diabetic and obese women. A ‘minor’ (+) problem was assigned when one or two of these characteristics were present and a ‘larger’ (++) problem if there were three or moreIn this item, (0) was considered when it cites the adjustments of the covariates that present distortions; (+) when the article reports adjustment, but does not specify the criteria; (++) when distortion was identified, without adjustment |
| Summary questions | Bias: are the results erroneously biased in a certain direction?Confounding: are there any serious confusing or other distorting influences?Chance: is it likely that the results occurred by chance? | ‘Yes’ or ‘No’ answers were assigned for each question. If the answer is ‘No’ to the three questions, the article is considered reliable, with a low risk of bias |
Figure 1.Flow diagram of databases searched according to PRISMA guidelines.
PRISMA, Preferred Reporting Items for Systematic Review and Meta-Analysis.
Summary of characteristics and results of the included studies.
| Authors/study design | Participants | Age | Periodontitis diagnosis | Arthritis diagnosis | Statistical analysis | Results | Outcomes | ||
|---|---|---|---|---|---|---|---|---|---|
| Clinical | Laboratorial | Clinical | Laboratorial | ||||||
| Arkhema et al.,[ | 58.5 years | Questionnaire- self-report of periodontal surgery or tooth loss in the last two years | None | Questionnaire self-report of connective tissue disease or had been diagnosed with RA by a physician in the last 2 years | None | Cox regression analysis | RA prognosis for women with periodontal surgery (RR = 1.24; 95% CI 0.83–1.83); | No significant risk of RA for women with periodontal surgery or tooth loss | |
| Chou et al.,[ | PD: 43.9 ± 17.1; DS: 32.1 ± 15.5; PD-DS diagnosis group: | ICD9-CM codes 523.3–523.5) | None | At least one ambulatory visit with a diagnosis of RA (ICD9-CM code 714.0) | None | Cox regression analysis; RR and HRs | Risk of RA with PD (HRs 1.89 and 1.43; 95% CI 1.56–2.29) | Higher risk of RA development for PD cohort and DS cohort (non-PD cohort as reference) PD cohort had a higher risk of RA than the non-PD and PD scale | |
| De Pablo et al.,[ | PD: 46 ± 8 years; | Clinical and radiographical evaluation | None | Prognosis for RA autoantibodies: CCP, MCV; CEP-1; cit-vim; cit-fib; anti-CParg (negative control of CCP); REP-1; antivimentin | Serum samples of patients with and without PD: ELISA | Chi-square, | PD | Antibody response in PD is predominantly directed to the uncitrullinated peptides of the RA autoantigens | |
| Demmer et al.,[ | 9702 | 0–4 MT ( | CPI | None | RA definition by self-report of physician diagnosis or physical examination data corresponding to criteria 1–4 of the American Rheumatism Association (1987 criteria) | None | Multivariable logistic regression analysis: hazard ratios | Incident RA ORs in gingivitis 1.32 (0.85–2.06) and PD 1.00 (0.68–1.48) | Although participants with periodontal disease or ⩾5 MT experienced |
| Dominguez et al.,[ | Control: 48.8 ± 9.86; PD: 45.25 ± 12.0; | Probing depth Clinical and CAL | None | Performed by a rheumatologist in | IL-1α + 4845 (rs17561); IL-1α + 889 (rs1800587); IL-1β + 3954 (rs1143634), IL-1β | Multiple linear and logistic regression | No significant association in the genotype frequencies of TNF-α 308 and IL-1α + 4845 SNPs | Genotypes and Haplotypes of Il-1b are related with PD and RA | |
| Mikuls et al.,[ | 322: Autoantibody negative for RA: 171; autoantibody positive for RA: 113; high risk for PD: 38. | Autoantibody negative for RA: 44 ± 14; autoantibody positive for RA: 48 ± 15; high risk for PD: 51 ± 16. | Self-reported questionnaire about PD signs. | Immunoglobulins of PD-pathogen: anti- | Physician diagnosis or physical (American College of Rheumatology criteria, 1987) | Autoantibodies of RA– ACPA; Rheumatoid factor | Multiple linear regression | Anti- | Immunity to |
| Reichert et al.,[ | 42 patients with RA; Controls: 114 | Controls: mean age 53.8 ± 16.7 years; | API, BOP; MT; CAL | DNA assessment of | The patients with RA were diagnosed by experienced rheumatologists (CS, GK) according to current criteria for classifying RA and spondyloarthropathies | None | Chi-square; Fisher’s exact test, Spearman’s correlation | In patients with RA, DNA of | DNA of periodontopathogens can be found in synovial fluid and oral bacteria may play a role in the pathogenesis of arthritis |
| Terao et al., 2015[ | 53.2 ± 13.43 | MT, CPI and CAL | None | Relationship between ACPA positivity and IgM-RF with periodontal status | RF ACPA | Logistic regression | MT–ACPA positivity: OR 95% = 1.03 (1.00–1.05); | The significant associations between PD parameters and positivity and levels of ACPA in healthy population support the major involvement of PD with ACPA production | |
| Thé and Ebersole,[ | Normal: | Not described | Assessement of PD oral pathogens antibodies: | Assessment of IgM-RF levels on sera and its association with PD oral pathogens | Assessment of IgM-RF levels on sera and its association with PD oral pathogens | Not described in text | 16 of 171 (9.4%) seropositive for IgM-RF | The chronic | |
ACPA, antibodies to citrullinated protein antigens; ADP, advanced destructive periodontitis; anti-CParg, (negative control of CCP); API, plaque index; BOP, bleeding on probing; CAL, clinical attachment level/loss; CCP, anticyclic citrullinated peptide; CEP-1, anticitrullinated α-enolase peptide-1; CI, confidence interval; cit-vim, anticitrullinated vimentin, cit-fib, anticitrullinated fibrinogen; CS, cross-sectional; CPI, Community Plaque Index; DNA, deoxyribonucleic acid; DS, dental scaling; HR, hazard ratio; ICD9-CM, International Classification of Diseases, 9th edition, Clinical Modification; IgM, immunoglobulin M; LA, loss of attachment; MCV, antimutated citrullinated vimentin; MT, missing teeth; non-PD, nonperiodontitis; OR, odds ratio; PD, periodontitis; PI, Periodontal Index; RA, rheumatoid arthritis; REP-1, antiarginine-containing α-enolase peptide-1; RF, rheumatoid factor; RR, relative risk.
Quality assessment of studies included, according to Fowkes and Fulton.[13]
| Checklist | Arkema et al.[ | Chou et al.[ | De Pablo et al.[ | Demmer et al.[ | Dominguez et al.[ | Mikuls et al.[ | Reichert et al.[ | Terao et al.[ | Thé et al.[ | |
|---|---|---|---|---|---|---|---|---|---|---|
| Study design appropriate to objectives? | Objective common design | |||||||||
| Prevalence cross-sectional | ||||||||||
| Prognosis cohort | 0 | 0 | 0 | 0 | ||||||
| Treatment-controlled trial | ||||||||||
| Cause cohort, case control, cross-sectional | 0 | 0 | 0 | 0 | 0 | |||||
| Study sample representative? | Source of sample | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
| Sampling method | 0 | 0 |
| 0 |
| 0 |
|
|
| |
| Sample size | 0 | 0 |
| 0 |
| 0 |
| 0 |
| |
| Entry criteria/exclusion |
|
|
|
|
|
| 0 | 0 | 0 | |
| Nonrespondents | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Control group acceptable? | Definition of controls | 0 | 0 | NA | NA | 0 | NA | 0 | NA |
|
| Source of controls | 0 | 0 | NA | NA |
| NA |
| NA | 0 | |
| Matching/randomization | NA |
| NA | NA |
| NA | 0 | NA | 0 | |
| Comparable characteristics | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | |
| Quality of measurements and outcomes? | Validity |
| 0 | 0 |
| 0 | 0 | 0 | 0 |
|
| Reproducibility | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 |
| |
| Blindness | 0 | 0 | 0 | 0 | NA | 0 | 0 | 0 | 0 | |
| Quality control |
| 0 |
| 0 | 0 | 0 | 0 | 0 |
| |
| Completeness | Compliance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dropouts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Deaths | NA | NA | NA | NA | 0 | NA | NA | NA | 0 | |
| Missing data | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Distorting influences? | Extraneous treatments | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 |
| Contamination |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Changes over time | 0 | 0 | 0 | 0 | 0 | 0 |
|
| 0 | |
| Confounding factors |
|
| 0 |
|
|
| 0 | 0 | 0 | |
| Distortion reduced by analysis | 0 | 0 | NA | NA | 0 | 0 | NA | 0 | NA | |
| Bias: are the results erroneously biased in a certain direction? | Yes | No | No | Yes | No | No | No | No | Yes | |
| Confounding: | Yes | No | No | Yes | No | No | No | No | Yes | |
| Chance: is it likely that the results occurred by chance? | No | No | No | No | No | No | No | No | Yes | |
0, no problem; +, minor problem; ++, major problem; NA, not applicable due to type of study.
Figure 2.Forest plot of meta-analysis for three studies (I2 = 96%).
The association between periodontitis and RA.
CI, confidence interval; M-H, Mantel-Haenszel method; RA, rheumatoid arthritis.
Figure 3.Forest plot of meta-analysis for two studies (I2 = 69%).
The association between periodontitis and RA.
CI, confidence interval; M-H, Mantel-Haenszel method; RA, rheumatoid arthritis.